Big Oil Earnings Season Marks A Return To Basics With Lower Profits — Neutral
XOM Forbes — November 10, 2025The ‘Big Oil' quarterly earnings season ended last week, as one energy major after another posted relatively lower profits compared to bumper ones from three years ago. But there was one other commonality between them all - a clear and firm return to oil and gas basics.
The sale comes as private-equity firms are increasing investment in the aerospace and defense sector.
WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
WAL GlobeNewsWire — November 10, 2025NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.
Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56 — Positive
ABM ADM ADP BKH CBSH CDUAF CWT FRT FTS GRC HRL HTO KMB KO KVUE MO MSEX NWN PPG RLI SCL SWK SYY TGT TR Seeking Alpha — November 10, 2025The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by November 2026, with Stepan, H2O America, and National Fuel Gas among the top projections.
Incyte Corporation (INCY) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript — Neutral
INCY Seeking Alpha — November 10, 2025Incyte Corporation ( INCY ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:00 AM EST Company Participants William Meury - CEO, President & Director Pablo Cagnoni - President and Head of Research & Development Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division All right. So welcome to this fireside chat with Incyte.
New management continues to execute the Goodyear Forward Plan. U.S. trade policies provide Goodyear with a competitive financial advantage over international rivals. Temporary issues hinder the operating margins of the industry.
Carronade Capital Issues Investor Presentation Detailing the Need for Change at Cannae Holdings — Neutral
CNNE GlobeNewsWire — November 10, 2025Outlines Key Initiatives to Reverse Chronic Underperformance, Restore Investor Confidence, Improve Governance, and Drive Value Creation at Cannae
Tesla chair thanks investors for approving Musk's $878 billion pay package — Positive
TSLA Reuters — November 10, 2025Tesla board chair Robyn Denholm thanked the electric-vehicle maker's shareholders on Monday for approving CEO Elon Musk's $878 billion pay package.
Visa and MasterCard Strike a Fee Deal. The Winners and Losers. — Neutral
MA V Barrons — November 10, 2025The agreement would allow merchants to lower fees and reject certain credit cards. But what does it mean for the stocks—and shoppers.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX — Neutral
MLTX Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Stride, Inc. (LRN) Plunges 49% as Platform Upgrade Fails, Triggering Hagens Berman Probe – Hagens Berman — Neutral
LRN GlobeNewsWire — November 10, 2025SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prominent shareholder rights law firm Hagens Berman is investigating Stride, Inc. (NYSE: LRN), the online education platform, for potential violations of the U.S. securities laws following a series of negative market events and serious fraud allegations that have seen the company's stock price plummet. The firm urges investors in Stride who suffered significant losses to submit your losses now.
Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript — Neutral
EXEL Seeking Alpha — November 10, 2025Exelixis, Inc. ( EXEL ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:30 AM EST Company Participants Michael Morrissey - CEO, President & Director Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division Welcome to this next fireside chat with Exelixis. With us today, we have Mike Morrissey, President and CEO.
Pagaya Technologies Ltd. (PGY) Q3 2025 Earnings Call Transcript — Neutral
PGY Seeking Alpha — November 10, 2025Pagaya Technologies Ltd. ( PGY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Josh Fagen - Head of Investor Relations & COO of Finance Gal Krubiner - CEO, Co-Founder & Director Sanjiv Das - Co-Founder & President Evangelos Perros - Chief Financial Officer Conference Call Participants John Hecht - Jefferies LLC, Research Division Peter Christiansen - Citigroup Inc., Research Division Harold Goetsch - B.
YPF Sociedad Anónima (YPF) Q3 2025 Earnings Call Transcript — Neutral
YPF Seeking Alpha — November 10, 2025YPF Sociedad Anónima ( YPF ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Margarita Chun - Investor Relations Officer Horacio Marin - CEO & Non Independent Chairman Maximiliano Westen - Strategy, New Businesses and Controlling Vice President Pedro Kearney - Vice President of Finance Conference Call Participants Alejandro Anibal Demichelis - Jefferies LLC, Research Division Leonardo Marcondes - BofA Securities, Research Division Daniel Guardiola - Banco BTG Pactual S.A., Research Division Guilherme Costa Martins - Goldman Sachs Group, Inc., Research Division Tasso Vasconcellos - UBS Investment Bank, Research Division Presentation Margarita Chun Investor Relations Officer …
Repligen Corporation (RGEN) Presents at UBS Global Healthcare Conference 2025 Transcript — Neutral
RGEN Seeking Alpha — November 10, 2025Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of Investor Relations Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division All right. With that, we're ready to kick things off.
Cogent Biosciences, Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript — Neutral
COGT Seeking Alpha — November 10, 2025Cogent Biosciences, Inc. ( COGT ) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 10, 2025 8:00 AM EST Company Participants Christi Waarich - Senior Director of Investor Relations Andrew Robbins - President, CEO & Director Conference Call Participants Neeta Somaiah Anupam Rama - JPMorgan Chase & Co, Research Division Paul Jeng - Guggenheim Securities, LLC, Research Division Amanda Acosta-Ruiz - Leerink Partners LLC, Research Division Samuel Slutsky - LifeSci Capital, LLC, Research Division Christopher Raymond - Raymond James & Associates, Inc., Research Division Yuxi Dong - Jefferies LLC, Research Division Presentation Operator Good …
Amazon's $150 Billion AI Capex Surge Could Force Its First Big Bond Deal In Years — Positive
AMZN Benzinga — November 10, 2025For a company that practically prints cash, Amazon.com Inc. (NASDAQ:AMZN) might soon need Wall Street's help again. The e-commerce and cloud giant has not issued a major bond deal since 2021, when it raised $18.5 billion to fund the MGM acquisition — its last significant borrowing in over four years.
Northborne Partners Advises Disdero Lumber Company on its Sale to BlueLinx Holdings — Neutral
BXC PRNewsWire — November 10, 2025MINNEAPOLIS , Nov. 10, 2025 /PRNewswire/ -- Northborne Partners is pleased to announce that it served as financial advisor to Tumac Lumber Company ("Tumac") in connection with the sale of its subsidiary, Disdero Lumber Company ("Disdero"), to BlueLinx Holdings ("BlueLinx"). Founded in 1953 and headquartered in Clackamas, Oregon, Disdero is a leading value-added wholesale distributor of a broad range of premium specialty forest products and other premium building materials used primarily in the construction of custom single-family homes and high-end multi-family residential projects.
Lofty Valuations, Overheated Technicals - Managing Market Risk With Victor Dergunov — Negative
PLTR TSLA Seeking Alpha — November 10, 2025As markets hit highs and AI stocks dominate the headlines, is the rally running on fumes? The Financial Prophet, Victor Dergunov, breaks down the risks of overheated technicals, stretched valuations, and the growing disconnect between Wall Street and the real economy.
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm — Neutral
BAX GlobeNewsWire — November 10, 2025NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).